Matulya Multispeciality Hospital And Research Center Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-01-2025
- Paid Up Capital ₹ 1.00 M
as on 10-01-2025
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 81.43%
(FY 2020)
- Profit 11.00%
(FY 2020)
- Ebitda 49.56%
(FY 2020)
- Net Worth 13.37%
(FY 2020)
- Total Assets -3.75%
(FY 2020)
About Matulya Multispeciality Hospital And Research Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shyam Tomar and Raja Bai serve as directors at the Company.
- CIN/LLPIN
U85190MP2018PTC046423
- Company No.
046423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Gwalior, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Matulya Multispeciality Hospital And Research Center?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Tomar  | Director | 28-Aug-2018 | Current |
| Raja Bai | Director | 29-Jan-2024 | Current |
Financial Performance of Matulya Multispeciality Hospital And Research Center.
Matulya Multispeciality Hospital And Research Center Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 81.43% increase. The company also saw a substantial improvement in profitability, with a 11% increase in profit. The company's net worth Soared by an impressive increase of 13.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Matulya Multispeciality Hospital And Research Center?
Unlock access to Matulya Multispeciality Hospital And Research Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mdvs Pharmaceuticals Private LimitedActive 6 years 7 monthsShyam Tomar and Raja Bai are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Matulya Multispeciality Hospital And Research Center?
Unlock and access historical data on people associated with Matulya Multispeciality Hospital And Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Matulya Multispeciality Hospital And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Matulya Multispeciality Hospital And Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
